Impact BioMedical Inc. Announces Pricing of Initial Public Offering
Impact BioMedical, Inc. (IBO)
Company Research
Source: GlobeNewswire
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the pricing of its initial public offering of 1,500,000 shares of its common stock at a public offering price of $3.00 per share. The shares are expected to begin trading on the NYSE American Market on September 16, 2024, under the ticker symbol “IBO.” The offering is expected to close on September 17, 2024, subject to the satisfaction of customary closing conditions. In addition, Impact has granted the underwriters a 45-day option to purchase an additional 225,000 shares of its common stock at the public offering price, less underwriting discounts, and commissions. All of the shares of common stock are being offered by Impact Biomedical. Revere Securities, LLC is the book-running manager for the offering. We have agreed to issue to the underwriter warrants to purchase up to 75,000 shares of ou
Show less
Read more
Impact Snapshot
Event Time:
IBO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IBO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IBO alerts
High impacting Impact BioMedical, Inc. news events
Weekly update
A roundup of the hottest topics
IBO
News
- Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision [Yahoo! Finance]Yahoo! Finance
- Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic VisionGlobeNewswire
- Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory DiseaseGlobeNewswire
- Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and AffiliatesGlobeNewswire
- Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent IssueGlobeNewswire
IBO
Sec Filings
- 11/12/24 - Form 10-Q
- 9/19/24 - Form 4
- 9/18/24 - Form 4
- IBO's page on the SEC website